CVKD
NASDAQ · Pharmaceuticals
Cadrenal Therapeutics Inc
$6.52
-0.45 (-6.46%)
Open$6.84
Previous Close$6.97
Day High$7.11
Day Low$6.40
52W High$20.14
52W Low$4.91
Volume—
Avg Volume31.1K
Market Cap16.30M
P/E Ratio—
EPS$-7.82
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+160.0% upside
Current
$6.52
$6.52
Target
$16.95
$16.95
$12.65
$16.95 avg
$22.59
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.07M | 2.13M | 1.91M |
| Net Income | 662.5K | 666.1K | 461.6K |
| Profit Margin | 32.0% | 31.3% | 24.1% |
| EBITDA | 955.8K | 1.01M | 1.06M |
| Free Cash Flow | 570.9K | 515.8K | 427.8K |
| Rev Growth | +2.5% | +18.2% | +2.4% |
| Debt/Equity | 0.18 | 0.20 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |